Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Wheeler Kurt
Relationship:   10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   8,638,466    

Indirect Shares

   50,230,112      
Direct Value   $53,673,527    

Indirect Value

   $221,892,016      
Total Shares   58,868,578      
Total Value   $275,565,543      


Rigel Pharmaceuticals Inc $4,407,795 Somaxon Pharmaceuticals, Inc. $0 Oxford Immunotec Global Plc $49,199,920 Sientra, Inc. $65,811 Rigel Pharmaceuticals Inc $4,407,795 Somaxon Pharmaceuticals, Inc. $0 Oxford Immunotec Global Plc $49,199,920 Sientra, Inc. $65,811
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    6    

     Stock price went up :
    1   
    6    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   6.0   
     Percentage Gain/Loss :
   12.5%
 44.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Rigel Pharmaceuticals Inc RIGL 10% Owner 2003-06-26 3,612,947 2004-09-13 475,026    Premium*  
            Cyclacel Pharmaceuticals Inc CYCC 10% Owner 0 2004-03-16 87,899    Premium*  
            Hemosense Inc HEM Director, 10% Owner 2005-07-01 0 2007-11-06 0    Premium*  
            American Cryostem Corporation CRYO Director, 10% Owner 2005-07-13 0 2008-05-28 0    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX Director, 10% Owner 2009-12-31 57,377 2009-12-31 4,632,562    Premium*  
            Poniard Pharmaceuticals PARD 10% Owner 0 2009-11-09 6,363,249    Premium*  
            Affymax Inc AFFY 10% Owner 0 2006-12-20 1,600,469    Premium*  
            Helicos Biosciences Corp HLCSQ 10% Owner 2007-05-30 0 2007-05-30 2,987,769    Premium*  
            Ithaka Acquisition Corp ITHKU Director, 10% Owner 0 2007-06-21 2,672,568    Premium*  
            Aryx Therapeutics Inc ARYX 10% Owner 2007-11-13 0 2008-11-14 5,364,572    Premium*  
            Epirus Biopharmaceuticals Inc EPRS 10% Owner 0 2011-10-27 11,133,961    Premium*  
            Aveo Pharmaceuticals Inc AVEO Former 10% Stockholder 2010-03-17 0 2010-03-17 2,208,961    Premium*  
            Zogenix, Inc. ZGNX Director, 10% Owner 2010-11-29 0 2010-11-29 5,982,439    Premium*  
            Humanigen Inc HGEN 10% Owner 2013-02-05 0 2013-02-05 2,632,928    Premium*  
            Aerie Pharmaceuticals Inc AERI 10% Owner 2015-01-28 0 2013-10-25 0    Premium*  
            Oxford Immunotec Global Plc OXFD 10% Owner 2015-06-16 2,237,377 2013-11-22 0    Premium*  
            Radius Health Inc. RDUS Former 10% stockholder 2014-06-06 0 2016-09-27 2,459,804    Premium*  
            Iveric Bio Inc ISEE 10% Owner 2015-05-26 0 2014-06-11 4,500    Premium*  
            Sientra, Inc. SIEN 10% Owner 2014-10-28 2,730,765 0    Premium*  
            Entasis Therapeutics Holdings Inc. ETTX 10% Owner 2018-09-28 0 2018-09-28 1,623,405    Premium*  
* Premium Members only  

Records found :    137         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-08-17 4 S $22.44 $305,216 I/I (13,599) 1,810,824 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-08-18 4 S $21.80 $117,720 I/I (5,400) 1,805,424 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-08-19 4 S $21.77 $108,847 I/I (5,000) 1,800,424 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-08-20 4 S $21.84 $600,619 I/I (27,499) 1,772,925 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-08-25 4 S $19.77 $16,330 I/I (826) 1,772,099 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-08-31 4 S $20.60 $1,246,626 I/I (60,527) 1,711,572 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-09-01 4 S $21.13 $517,719 I/I (24,500) 1,687,072 -
PARD Poniard Pharmaceuticals 10% Owner   –       –       •   2006-04-26 3 IO $0.00 $0 I/I 0 35,749,286 -
AFFY Affymax Inc 10% Owner   –       –       •   2006-12-14 3 IO $0.00 $0 I/I 0 31,248 -
AFFY Affymax Inc 10% Owner   –       –       •   2006-12-19 4 D $25.00 $1,823,575 I/I (72,943) 65,571 0 -
AFFY Affymax Inc 10% Owner   –       –       •   2006-12-19 4 OE $17.00 $1,823,522 I/I 107,266 138,514 0 -
AFFY Affymax Inc 10% Owner   –       –       •   2006-12-20 4 A $0.00 $0 I/I 1,534,898 1,600,469 0 -
PARD Poniard Pharmaceuticals 10% Owner   –       –       •   2007-04-30 4 B $6.33 $5,697,000 I/I 900,000 6,858,211 1.5 -
HLCSQ Helicos Biosciences Corp 10% Owner   –       –       •   2007-05-30 4 A $0.00 $0 I/I 2,654,436 2,654,436 0 -
HLCSQ Helicos Biosciences Corp 10% Owner   –       –       •   2007-05-30 4 B $9.00 $2,999,997 I/I 333,333 2,987,769 1.5 -
ARYX Aryx Therapeutics Inc 10% Owner   –       –       •   2007-11-13 4 A $0.00 $0 I/I 3,276,862 3,276,862 0 -
ARYX Aryx Therapeutics Inc 10% Owner   –       –       •   2007-11-13 4 B $10.00 $3,000,000 I/I 300,000 3,576,862 1.5 -
ARYX Aryx Therapeutics Inc 10% Owner   –       –       •   2008-11-14 4 B $2.20 $3,932,962 I/I 1,787,710 5,364,572 1.5 -
PARD Poniard Pharmaceuticals 10% Owner   –       –       •   2009-11-05 4 S $8.00 $626,292 I/I (78,262) 6,779,949 0 -
PARD Poniard Pharmaceuticals 10% Owner   –       –       •   2009-11-06 4 S $8.06 $2,132,560 I/I (264,648) 6,515,301 0 -
PARD Poniard Pharmaceuticals 10% Owner   –       –       •   2009-11-09 4 S $8.50 $1,292,442 I/I (152,052) 6,363,249 0 -
EPRS Epirus Biopharmaceuticals... 10% Owner   –       –       •   2009-12-21 3 IO $0.00 $0 I/I 0 22,547,613 -
EPRS Epirus Biopharmaceuticals... 10% Owner   –       –       •   2010-01-01 4 D $0.00 $0 I/I (7,913,653) 14,633,961 0 -
EPRS Epirus Biopharmaceuticals... 10% Owner   –       –       •   2011-09-26 4 S $1.11 $233,100 I/I (210,000) 14,423,961 0 -
EPRS Epirus Biopharmaceuticals... 10% Owner   –       –       •   2011-09-27 4 S $1.09 $218,000 I/I (200,000) 14,223,961 0 -
  137  Records found
  1   2  3   4   5   6      
  Page 2 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us